Suchergebnisse - "Coyle, Vicky"

PubPharm (47)

1

A Phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301)

enthalten in: ResearchSquare.com | 2024

von Spiliopoulou, P. | Kazmi, F. | Aroldi, F. | +12

2

A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301)

enthalten in: Journal of experimental & clinical cancer research : CR | 2024

von Spiliopoulou, P. | Kazmi, F. | Aroldi, F. | +12

3

A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301)

enthalten in: Journal of experimental & clinical cancer research | 2024

von Spiliopoulou, P. | Kazmi, F. | Aroldi, F. | +12

4

Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis : the EASI-SWITCH RCT

enthalten in: Health technology assessment (Winchester, England) | 2024

von Coyle, V. | Forde, C. | Adams, R. | +14

5

Prehabilitation provision and practice in the UK : a freedom of information survey

enthalten in: British journal of anaesthesia | 2024

von Pufulete, M. | Coyle, V. | Provan, D. | +7

6

Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH) : a randomized non-inferiority trial

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2024

von Coyle, V. | Forde, C. | McAuley, D. | +14

7

Clinical positioning of the IAP antagonist tolinapant (ASTX660) in colorectal cancer

enthalten in: bioRxiv.org | 2023

von Crawford, N. | Stott, K. | Sessler, T. | +14

8

Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Taylor, K. | Zou, J. | Magalhaes, M. | +9

CommentIn: Eur J Cancer. 2023 Dec;195:113372. - PMID 37913682

9

A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and other advanced solid tumours

enthalten in: British journal of cancer | 2022

von El Helali, A. | Plummer, R. | Jayson, G. | +10

10

Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer

enthalten in: Molecular cancer therapeutics | 2021

von Crawford, N. | Stott, K. | Sessler, T. | +15

1
2
3
4
5
Nächster »
[5]